This article reviews the research advancements surrounding HIF-1α and DKD, while exploring the clinical prospects of zinc as a therapeutic agent via the HIF-1α pathway for DKD, with the aim of providing reference and insight for future research. The gene discussed is HIF1A; the disease is diabetic kidney disease.